Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease - Chang et al. 2020

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

© 2020 Chang, Yang, Yang, Chang and Wu

Frontiers in Neurology

Previous
Previous

Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome

Next
Next

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease